← Back to Entity Graph

Cooper Rice-Brading Foundation Ltd

Concentration Risk
FoundationRegistryHPCABN 50623689109NSW
Relationships
21
Data Sources
2
Revenue
$1.1M
Total Outbound
$1.0M
Preview
Data as of: 15 Mar 2026

About

The Cooper Rice-Brading Foundation Ltd is an Australian philanthropic organisation dedicated to advancing sarcoma research through funding and awareness initiatives. It aims to find a cure for sarcoma, promote early diagnosis, and provide comprehensive support for sarcoma patients and their families, particularly focusing on young people affected by the disease in NSW and nationally.

Giving Philosophy

The foundation primarily funds clinical research initiatives aimed at finding a cure for sarcoma, often through collaborative partnerships with other research bodies and foundations. It also directly supports sarcoma patients and their families through psychological, practical, and advocacy programs from diagnosis through treatment and beyond. They value impactful, targeted research and holistic patient care.

Wealth Source:As a corporate foundation, its wealth is generated through fundraising efforts, including celebrity endorsements and challenges, as well as partnerships with government and other

Tips for Applicants

Prospective applicants should focus on sarcoma-specific clinical research projects or patient support programs that align with the foundation's dual mission of research advancement and family support. Organizations should demonstrate collaborative capacity and ability to serve young sarcoma patients and their families, ideally with evidence of impact in early diagnosis, treatment innovation, or psychosocial support.

Programs & Opportunities (1)

Sarcoma Accelerator Programme
grant · Closes 2026-06-30
$1.0M

Funds the development of precision therapies for childhood sarcomas through a collaborative, crowdsourced research model.

Notable Grants

  • $373,000 for the sarcoma specific phosphoproteomic study
  • $312,000 for the Paediatric Preclinical Sarcoma Biobank

Financial History (6 years)

YearRevenueExpensesAssetsSurplus
2023$1.1M$208K$1.2M$872K
2022$280K$277K$287K$2K
2021$376K$367K$285K$9K
2020$160K$43K$277K$117K
2019$165K$41K$159K$124K
2018$44K$10K$35K$35K
0
Grants Given (AU)
$111K
0
Volunteers
20
Donations Received
$1.1M

Community Evidence

External Evidence

Identity

GS ID
AU-ABN-50623689109
ABN
50623689109
Sector
health
Financial Year
2023

Focus Areas

Themes
healthresearch
Geography
AU-NSW
Target Recipients
YouthChildrenAdultsAged personsFamiliesPeople with chronic illness
Purposes
Health
Beneficiaries
AdultsAgedChildrenEarly ChildhoodFamiliesChronic IllnessYouth

Board & Leadership

  • Prof David Thomas - Chair
  • Dr Vera Terry - Board Member

Financials

Revenue
$1.1M
Assets
$1.2M

Method

Match Confidence
registry
Cross-references
2 datasets
Match Key
ABN
Relationships
21

Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.

Data Sources

ACNCFoundations

Location Intelligence

Postcode
2011
Locality
Potts Point - Woolloomooloo
Remoteness
Major Cities of Australia
SEIFA Disadvantage
Decile 8/10
LGA
Sydney
Entities in Area
330
View on Power Map